Deal time

Ankur Drugs28 Avon Organics15 Lyka Laboratories21 Strides Arcolab21 Surya Pharmaceuticals30 Venus Remedies26

Action on pharma counters
While the BSE Sensex has lost 10 per cent in the last one month and had a measly 8 per cent gain over the last one year, the BSE Healthcare index has gained 6 per cent over the last one month and 19 per cent over the last one year.

The scrips of Ranbaxy, Sun Pharma, Cipla and Dr Reddy's are near their 52-week highs. Investors who wish to expand their portfolio in the pharma sector can look at Lupin Labs (Margin expansion, growth prospects, attractive valuations 16x FY09 EPS of Rs 44), Dishman Pharma (Earnings visibility, inexpensive valuations at 15x FY09 EPS of Rs 20) and Cadila Healthcare (Good growth prospects, attractive valuations at 13x FY09 EPS of 24).